Skip to main content
. Author manuscript; available in PMC: 2013 Apr 15.
Published in final edited form as: Mod Pathol. 2012 Feb 10;25(6):805–814. doi: 10.1038/modpathol.2012.1

Figure 2.

Figure 2

A) Molecular evaluation of laser-microdissected CD34+ cells in angioimmunoblastic T-cell lymphoma: they express CD31 and not CD10, thus confirming the molecular profile of endothelial cells (left).

Molecular evaluation of laser-microdissected CD3+CD10+ cells in angioimmunoblastic T-cell lymphoma: they express CD10 and not CD31, thus confirming the molecular profile of lymphoma cells (right).

B) Molecular evaluation of laser-microdissected CD34+ cells in lymph node hyperplasia: they express CD31 and not CD10, thus confirming the molecular profile of endothelial cells (left).

Molecular evaluation of laser-microdissected CD3+ cells in lymph node hyperplasia: they express CD3ε and not CD31, thus confirming the molecular profile of lymphocytes (right).

C) The expression of BCL2 mRNA in laser-microdissected CD34+ angioimmunoblastic T-cell lymphoma endothelial cells is significantly correlated with VEGFA mRNA expression levels in the same laser-microdissected cell population (left). BCL2 and VEGFA mRNA expression levels are not correlated in the same laser-microdissected cell population of CD3+CD10+ lymphoma cells of angioimmunoblastic T-cell lymphoma (right).

D) In lymph node hyperplasia controls, no correlations are found between BCL2 and VEGFA mRNA expression levels whether for laser-microdissected CD34+ cells (left) or for laser-microdissected CD3+ lymphocytes (right).